PUBLISHER: The Business Research Company | PRODUCT CODE: 1994625
PUBLISHER: The Business Research Company | PRODUCT CODE: 1994625
High-throughput screening (HTS) services are laboratory services that use automated technologies to rapidly test thousands to millions of chemical, biological, or genetic compounds for activity against specific biological targets. These services often employ robotics, data analytics, and miniaturized assays to accelerate drug discovery and target identification. They help to efficiently identify potential drug candidates or bioactive compounds for further development in pharmaceutical and biotechnology research.
The primary types of high-throughput screening services include instruments, reagents and kits, and services. Instruments are automated systems designed to efficiently evaluate large volumes of biological or chemical compounds for activity, toxicity, or other relevant characteristics. These services employ technologies such as ultra-high-throughput screening (uHTS), cell-based assays, lab-on-a-chip platforms, and label-free technologies. They are applied across functional areas including target identification, primary screening, and toxicology, and are utilized by end users such as pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations (CROs).
Tariffs are impacting the high-throughput screening services market by increasing costs of imported robotic systems, detection instruments, assay reagents, microplates, and high-performance computing infrastructure. Pharmaceutical and biotechnology hubs in North America and Europe are most affected due to reliance on advanced imported laboratory equipment, while Asia-Pacific faces higher costs for service expansion and export-oriented instrument manufacturing. These tariffs are raising service prices and extending project timelines. However, they are also encouraging local instrument assembly, regional reagent production, and greater adoption of software-driven screening efficiencies.
The high-throughput screening services market research report is one of a series of new reports from The Business Research Company that provides high-throughput screening services market statistics, including high-throughput screening services industry global market size, regional shares, competitors with a high-throughput screening services market share, detailed high-throughput screening services market segments, market trends and opportunities, and any further data you may need to thrive in the high-throughput screening services industry. This high-throughput screening services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The high-throughput screening services market size has grown rapidly in recent years. It will grow from $23.02 billion in 2025 to $25.54 billion in 2026 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to expansion of pharmaceutical R&D activities, growing use of combinatorial chemistry libraries, adoption of automated liquid handling systems, increasing demand for rapid target identification, availability of large compound libraries.
The high-throughput screening services market size is expected to see rapid growth in the next few years. It will grow to $39.06 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to increasing investments in precision drug discovery, rising focus on biologics and complex targets, expansion of personalized medicine research, growing use of AI-assisted screening workflows, increasing outsourcing of screening services to CROs. Major trends in the forecast period include increasing use of automated robotic screening platforms, rising demand for ultra-high-throughput screening services, growing adoption of cell-based and label-free assays, expansion of AI-driven data analysis in drug discovery, enhanced focus on accelerating hit-to-lead identification.
The increasing prevalence of chronic and complex diseases is anticipated to drive the growth of the high-throughput screening services market. Chronic and complex diseases are long-duration conditions that involve multiple biological pathways, persist over long periods, and generally require ongoing management rather than short-term treatment. The incidence of these diseases is rising primarily due to aging global populations, lifestyle-related risk factors, and improved disease detection, which together are increasing pressure on healthcare systems and fueling demand for advanced therapeutic solutions. High-throughput screening (HTS) services support research on chronic and complex diseases by enabling the rapid and simultaneous assessment of large volumes of compounds against biological targets. This capability accelerates early-stage drug discovery, enhances target identification, and supports the development of more effective therapies for multifactorial and long-term conditions. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, approximately 76.4% of adults in the United States, representing more than 194 million individuals, reported having at least one chronic condition in 2023, while 51.4% (around 131 million people) reported having multiple chronic conditions. Therefore, the increasing prevalence of chronic and complex diseases is contributing to the growth of the high-throughput screening services market.
Leading companies operating in the high-throughput screening services market are focusing on innovation in miniaturized and high-density assays such as ultra-high screening speed with up to 27 detection channels to enable faster, large-scale multiparametric analysis and accelerate drug discovery workflows. Ultra-high screening speed with up to 27 detection channels refers to the ability to rapidly analyze multiple biological parameters simultaneously, increasing data output and efficiency in high-throughput screening studies. For example, in May 2024, Evotec SE, a Germany-based drug discovery and development services company, introduced comprehensive high-throughput screening services as part of its integrated early discovery platform. Evotec conducts large-scale biochemical and cell-based HTS campaigns using highly automated, miniaturized assay systems and advanced data analytics. The company supports pharmaceutical and biotechnology partners by rapidly identifying hit compounds and optimizing lead selection, thereby accelerating early-stage drug discovery programs.
In January 2023, Charles River Laboratories International, Inc., a US-based contract research organization (CRO), acquired SAMDI Tech, Inc. for an undisclosed amount. Through this acquisition, Charles River Laboratories seeks to enhance its drug discovery capabilities by incorporating SAMDI Tech's proprietary label-free, mass spectrometry-based high-throughput screening technologies, enabling faster hit identification, improved data quality, and accelerated early-stage drug development timelines. SAMDI Tech, Inc. is a US-based biotechnology company specializing in advanced mass spectrometry-driven assay platforms and high-throughput screening services for drug discovery.
Major companies operating in the high-throughput screening services market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Incorporated, Eurofins Scientific SE, Charles River Laboratories International Inc., Revvity Inc., Bio-Rad Laboratories Inc., Hamilton Company, Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Molecular Devices LLC, ShanghAI Medicilon Inc., Sygnature Discovery Limited, Selvita S.A., Cayman Chemical Company, Creative Bioarray Inc., Axxam S.p.A., Axcelead Inc., Creative Biolabs Inc., Enamine Ltd., Aurora Biomed Inc.
North America was the largest region in the high-throughput screening services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-throughput screening services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the high-throughput screening services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The high-throughput screening services market includes revenues earned by entities through development and optimization, compound library screening, target identification and validation, automated robotic screening, data analysis and reporting, hit-to-lead evaluation, and consulting services for drug discovery programs. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
High-Throughput Screening Services Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses high-throughput screening services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for high-throughput screening services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The high-throughput screening services market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.